Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
4(80.0%)
Phase 2
1(20.0%)
5Total
Phase 4(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07025980Phase 2Not Yet Recruiting

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Role: collaborator

NCT05124314Phase 4Unknown

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

Role: lead

NCT01860183Phase 4Completed

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Role: lead

NCT04280874Phase 4Completed

Induction of Labor in Term Pregnancies With Unfavourable Cervix

Role: lead

NCT03488771Unknown

Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients

Role: lead

NCT01510795Phase 4Unknown

Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology

Role: lead

All 6 trials loaded